🇺🇸 FDA
Pipeline program

AD-4833 15 mg

SYR-322-4833/CCT-901

Approved small_molecule completed

Quick answer

AD-4833 15 mg for Diabetes Mellitus is a Approved program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).

Program details

Company
Takeda
Indication
Diabetes Mellitus
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials